These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9599147)

  • 1. Triplet-repeat transcripts: a role for DNA in disease.
    Singer RH
    Science; 1998 May; 280(5364):696-7. PubMed ID: 9599147
    [No Abstract]   [Full Text] [Related]  

  • 2. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
    Philips AV; Timchenko LT; Cooper TA
    Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absconding with the threesome.
    Sachidanandan C
    Trends Cell Biol; 2001 Dec; 11(12):462. PubMed ID: 11719038
    [No Abstract]   [Full Text] [Related]  

  • 4. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.
    Michalowski S; Miller JW; Urbinati CR; Paliouras M; Swanson MS; Griffith J
    Nucleic Acids Res; 1999 Sep; 27(17):3534-42. PubMed ID: 10446244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
    Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.
    Fardaei M; Larkin K; Brook JD; Hamshere MG
    Nucleic Acids Res; 2001 Jul; 29(13):2766-71. PubMed ID: 11433021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophia myotonia: why focus on foci?
    Junghans RP
    Eur J Hum Genet; 2009 May; 17(5):543-53. PubMed ID: 19172994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy: discussion of molecular basis.
    Timchenko LT; Tapscott SJ; Cooper TA; Monckton DG
    Adv Exp Med Biol; 2002; 516():27-45. PubMed ID: 12611434
    [No Abstract]   [Full Text] [Related]  

  • 9. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles.
    Holt I; Mittal S; Furling D; Butler-Browne GS; Brook JD; Morris GE
    Genes Cells; 2007 Sep; 12(9):1035-48. PubMed ID: 17825047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.
    Tiscornia G; Mahadevan MS
    Mol Cell; 2000 Jun; 5(6):959-67. PubMed ID: 10911990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy: the role of RNA CUG triplet repeats.
    Timchenko LT
    Am J Hum Genet; 1999 Feb; 64(2):360-4. PubMed ID: 9973273
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular biology. Neutralizing toxic RNA.
    Cooper TA
    Science; 2009 Jul; 325(5938):272-3. PubMed ID: 19608901
    [No Abstract]   [Full Text] [Related]  

  • 13. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
    Mankodi A; Logigian E; Callahan L; McClain C; White R; Henderson D; Krym M; Thornton CA
    Science; 2000 Sep; 289(5485):1769-73. PubMed ID: 10976074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.
    Timchenko LT; Miller JW; Timchenko NA; DeVore DR; Datar KV; Lin L; Roberts R; Caskey CT; Swanson MS
    Nucleic Acids Res; 1996 Nov; 24(22):4407-14. PubMed ID: 8948631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains.
    Smith KP; Byron M; Johnson C; Xing Y; Lawrence JB
    J Cell Biol; 2007 Sep; 178(6):951-64. PubMed ID: 17846170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy.
    Mastroyiannopoulos NP; Shammas C; Phylactou LA
    Biol Cell; 2010 Jul; 102(9):515-23. PubMed ID: 20690904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.
    Wheeler TM; Sobczak K; Lueck JD; Osborne RJ; Lin X; Dirksen RT; Thornton CA
    Science; 2009 Jul; 325(5938):336-9. PubMed ID: 19608921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deconstructing myotonic dystrophy.
    Tapscott SJ
    Science; 2000 Sep; 289(5485):1701-2. PubMed ID: 11001736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
    Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
    Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A muscleblind knockout model for myotonic dystrophy.
    Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
    Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.